PMID- 1864928 OWN - NLM STAT- MEDLINE DCOM- 19910906 LR - 20210526 IS - 0095-1137 (Print) IS - 1098-660X (Electronic) IS - 0095-1137 (Linking) VI - 29 IP - 6 DP - 1991 Jun TI - Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms. PG - 1125-7 AB - To evaluate the usefulness of a human T-cell lymphotropic virus type I (HTLV-I) recombinant p21E immunoassay as a supplementary test in HTLV-I/II serologic testing algorithms, we used this assay to test 378 serum samples previously categorized as positive, indeterminant, or negative for HTLV-I/II antibody, as defined by U.S. Public Health Service guidelines. We found this test to be highly sensitive for detecting antibody to HTLV-I/II env (99.4%) but slightly less specific (96.0%), particularly among samples from intravenous drug users. Our data suggest that this test is most appropriately used to confirm the absence of env antibody in samples which are repeatably reactive in an HTLV-I/II screening assay and gag reactive only by immunoblotting. Because of the high sensitivity of this recombinant p21E test, a negative result in this context could preclude radioimmunoprecipitation testing. However, pending further evaluation of the specificity of this assay, samples testing positive for p21 env antibody may require confirmation by radioimmunoprecipitation, particularly in situations in which the results will be used for diagnostic purposes or blood donor counseling. FAU - Hartley, T M AU - Hartley TM AD - Retrovirus Diseases Branch, Centers for Disease Control, Atlanta, Georgia 30333. FAU - Malone, G E AU - Malone GE FAU - Khabbaz, R F AU - Khabbaz RF FAU - Lal, R B AU - Lal RB FAU - Kaplan, J E AU - Kaplan JE LA - eng PT - Journal Article PL - United States TA - J Clin Microbiol JT - Journal of clinical microbiology JID - 7505564 RN - 0 (Gene Products, env) RN - 0 (HTLV-I Antibodies) RN - 0 (HTLV-II Antibodies) RN - 0 (Retroviridae Proteins, Oncogenic) RN - 0 (env Gene Products, Human Immunodeficiency Virus) RN - 0 (gp21 protein, Human T-lymphotropic virus 1) SB - IM MH - Algorithms MH - Evaluation Studies as Topic MH - Gene Products, env/*immunology MH - HTLV-I Antibodies/*blood MH - HTLV-II Antibodies/*blood MH - Human T-lymphotropic virus 1/immunology MH - Humans MH - *Immunoenzyme Techniques MH - Retroviridae Proteins, Oncogenic/*immunology MH - env Gene Products, Human Immunodeficiency Virus PMC - PMC269955 EDAT- 1991/06/01 00:00 MHDA- 1991/06/01 00:01 PMCR- 1991/10/01 CRDT- 1991/06/01 00:00 PHST- 1991/06/01 00:00 [pubmed] PHST- 1991/06/01 00:01 [medline] PHST- 1991/06/01 00:00 [entrez] PHST- 1991/10/01 00:00 [pmc-release] AID - 10.1128/jcm.29.6.1125-1127.1991 [doi] PST - ppublish SO - J Clin Microbiol. 1991 Jun;29(6):1125-7. doi: 10.1128/jcm.29.6.1125-1127.1991.